Equine Pipeline

Metabolic Syndrome in Horses

KIND-015


KIND-015

Equine Metabolic Syndrome (EMS) facts:

No FDA-approved therapeutic

May result in life-threatening laminitis

The onset of laminitis is due to physiological changes and sensitivity of the laminar tissue

Characterized by obesity and regional adiposity

Underlying cause is an insulin resistance or insensitivity

“Laminitis causes pain and suffering, and it is imperative that we focus our efforts on diagnosing and managing Equine Metabolic Syndrome in order to prevent this devastating disease from occurring.”

– Nicholas Frank, DVM, PhD, DACVIM

Learn More About:

KindredBio Investor Relations Metabolic Syndrome in Horses

US-CORP-1900168 FEB-20

Equine Pipeline

Metabolic Syndrome in Horses

KIND-015

News

Events